{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"EPA-HQ-OAR-2006-0159\" sorted by posted_date descending", "rows": [["EPA-HQ-OAR-2006-0159-0060", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007", "Rule", "Federal Register Document", "2007-06-12T04:00:00Z", 2007, 6, null, null, "2011-06-11T16:02:03Z", "E7-11319", 0, 0, "090000648024eb61"], ["EPA-HQ-OAR-2006-0159-0061", "EPA", "EPA-HQ-OAR-2006-0159", "2007 Final Rule Submitted to OMB (Office of Management and Budget)", "Supporting & Related Material", "Federal Register Document", "2007-06-12T04:00:00Z", 2007, 6, null, null, "2011-06-11T16:02:05Z", null, 0, 0, "090000648024e9f4"], ["EPA-HQ-OAR-2006-0159-0051", "EPA", "EPA-HQ-OAR-2006-0159", "Second Letter to USEPA from the US Stakeholder Group on MDI Transition", "Supporting & Related Material", "Letter, Memorandum, Email", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2007-06-08T15:18:46Z", null, 0, 0, "090000648023dfc1"], ["EPA-HQ-OAR-2006-0159-0059", "EPA", "EPA-HQ-OAR-2006-0159", "FDA (Food and Drug Administration) Rulemaking: Use of Ozone-Depleting Substances; Removal of Essential-Use Designations (70 FR 17168)", "Supporting & Related Material", "Federal Register Document", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2011-06-11T16:02:04Z", null, 0, 0, "0900006480249f74"], ["EPA-HQ-OAR-2006-0159-0056", "EPA", "EPA-HQ-OAR-2006-0159", "Decision XII/2 from the 12th Meeting of the Montreal Protocol", "Supporting & Related Material", "Adjudication, Brief, Decision, Decree, Motion, Order", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2007-06-08T15:18:56Z", null, 0, 0, "0900006480249f5f"], ["EPA-HQ-OAR-2006-0159-0050", "EPA", "EPA-HQ-OAR-2006-0159", "Letter to USEPA from the US Stakeholders Group on MDI Transition", "Supporting & Related Material", "Letter, Memorandum, Email", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2007-06-08T15:18:44Z", null, 0, 0, "090000648023dfb7"], ["EPA-HQ-OAR-2006-0159-0053", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone: Allocation of Essential-Use Allowances for Calendar Year 2002; and Extension of the De Minimis Exemption for Essential Laboratory and Analytical Uses Through Calendar Year 2005; Final Rule (67 FR 6352)", "Supporting & Related Material", "Federal Register Document", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2011-06-11T16:02:03Z", null, 0, 0, "0900006480249f4b"], ["EPA-HQ-OAR-2006-0159-0055", "EPA", "EPA-HQ-OAR-2006-0159", "Decision XVIII/7 from the 18th Meeting of the Parties to the Montreal Protocol", "Supporting & Related Material", "Adjudication, Brief, Decision, Decree, Motion, Order", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2007-06-08T15:18:54Z", null, 0, 0, "0900006480249f5a"], ["EPA-HQ-OAR-2006-0159-0058", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone; Extension of Global Laboratory and Analytical Use Exemption for Essential Class I Ozone Depleting Substances (70 FR 77048)", "Supporting & Related Material", "Federal Register Document", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2011-06-11T16:02:03Z", null, 0, 0, "0900006480249f71"], ["EPA-HQ-OAR-2006-0159-0057", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2005; Final Rule (70 FR 49836)", "Supporting & Related Material", "Federal Register Document", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2011-06-11T16:02:03Z", null, 0, 0, "0900006480249f68"], ["EPA-HQ-OAR-2006-0159-0049", "EPA", "EPA-HQ-OAR-2006-0159", "Schering-Plough Letter to U.S. Government Stakeholders", "Supporting & Related Material", "Letter, Memorandum, Email", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2007-06-08T15:18:43Z", null, 0, 0, "090000648023dfa9"], ["EPA-HQ-OAR-2006-0159-0052", "EPA", "EPA-HQ-OAR-2006-0159", "Decision VIII/10 from the 8th Meeting of the Parties to the Montreal Protocol", "Supporting & Related Material", "Adjudication, Brief, Decision, Decree, Motion, Order", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2007-06-08T15:18:47Z", null, 0, 0, "0900006480249f47"], ["EPA-HQ-OAR-2006-0159-0054", "EPA", "EPA-HQ-OAR-2006-0159", "Decision XVII/5 from the 17th Meeting of the Parties to the Montreal Protocol", "Supporting & Related Material", "Adjudication, Brief, Decision, Decree, Motion, Order", "2007-06-08T04:00:00Z", 2007, 6, null, null, "2007-06-08T15:18:52Z", null, 0, 0, "0900006480249f56"], ["EPA-HQ-OAR-2006-0159-0044", "EPA", "EPA-HQ-OAR-2006-0159", "2007 Food and Drug Administration (FDA) Determination Letter (Revised, May 4, 2007)", "Supporting & Related Material", "Letter, Memorandum, Email", "2007-05-31T04:00:00Z", 2007, 5, null, null, "2007-05-31T14:43:58Z", null, 0, 0, "090000648024599b"], ["EPA-HQ-OAR-2006-0159-0043", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for CONFIDENTIAL supplementary information received by EPA from Robert M. Sussman of Latham and Watkins, LLC, council for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on February 22, 2007", "Supporting & Related Material", "Other", "2007-02-27T05:00:00Z", 2007, 2, null, null, "2007-02-27T18:26:42Z", null, 0, 0, "090000648020bd6b"], ["EPA-HQ-OAR-2006-0159-0033", "EPA", "EPA-HQ-OAR-2006-0159", "Notes from meeting between representatives from Amphastar Pharmaceuticals, Inc./Armstrong Pharmaceuticals Inc. and USEPA on November 30, 2006", "Supporting & Related Material", "Meeting/Teleconference Materials", "2006-12-06T05:00:00Z", 2006, 12, null, null, "2012-03-24T19:34:44Z", null, 0, 0, "09000064801e76bb"], ["EPA-HQ-OAR-2006-0159-0001", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007", "Proposed Rule", "Federal Register Document", "2006-11-03T12:49:10Z", 2006, 11, "2006-11-03T12:49:10Z", "2006-12-05T04:59:59Z", "2011-06-11T16:02:04Z", "E6-18581", 0, 0, "09000064801dd141"], ["EPA-HQ-OAR-2006-0159-0021", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for the Regulatory Impact Analysis RIA", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:45Z", null, 0, 0, "09000064801dbe94"], ["EPA-HQ-OAR-2006-0159-0008", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Schering Plough's response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:37Z", null, 0, 0, "09000064801db554"], ["EPA-HQ-OAR-2006-0159-0018", "EPA", "EPA-HQ-OAR-2006-0159", "SAMPLE 114 Letter for Allocation of Essential Use Allowances for Calendar Year 2007", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:43Z", null, 0, 0, "09000064801dbe5e"], ["EPA-HQ-OAR-2006-0159-0017", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Armstrong Pharmaceuticals, Inc.\u2019s response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:42Z", null, 0, 0, "09000064801dbe40"], ["EPA-HQ-OAR-2006-0159-0007", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Wyeth's response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:37Z", null, 0, 0, "09000064801db534"], ["EPA-HQ-OAR-2006-0159-0016", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc.\u2019s response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:42Z", null, 0, 0, "09000064801dbe3a"], ["EPA-HQ-OAR-2006-0159-0013", "EPA", "EPA-HQ-OAR-2006-0159", "Schering-Plough's response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:40Z", null, 0, 0, "09000064801dbd2b"], ["EPA-HQ-OAR-2006-0159-0015", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Wyeth's response to section 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:41Z", null, 0, 0, "09000064801dbe1d"], ["EPA-HQ-OAR-2006-0159-0023", "EPA", "EPA-HQ-OAR-2006-0159", "Decision IV/25- Essential uses", "Supporting & Related Material", "Guidance, Interpretation, Policy, Procedure", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:46Z", null, 0, 0, "09000064801dbef4"], ["EPA-HQ-OAR-2006-0159-0004", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:35Z", null, 0, 0, "09000064801d7f4b"], ["EPA-HQ-OAR-2006-0159-0006", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for 3M\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:36Z", null, 0, 0, "09000064801d7fbd"], ["EPA-HQ-OAR-2006-0159-0022", "EPA", "EPA-HQ-OAR-2006-0159", "Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2006", "Supporting & Related Material", "Federal Register Document", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2011-06-11T16:02:04Z", null, 0, 0, "09000064801dbedc"], ["EPA-HQ-OAR-2006-0159-0024", "EPA", "EPA-HQ-OAR-2006-0159", "Decision XVI/12-Essential-use nominations for Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol for controlled substances for 2005 and 2006", "Supporting & Related Material", null, "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:47Z", null, 0, 0, "09000064801dbf01"], ["EPA-HQ-OAR-2006-0159-0020", "EPA", "EPA-HQ-OAR-2006-0159", "Decision XVII/5: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2006 and 2007", "Supporting & Related Material", "Guidance, Interpretation, Policy, Procedure", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:44Z", null, 0, 0, "09000064801dbe7e"], ["EPA-HQ-OAR-2006-0159-0010", "EPA", "EPA-HQ-OAR-2006-0159", "SAMPLE 114 LETTER for CFC Stocks Owned", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:38Z", null, 0, 0, "09000064801dbcf0"], ["EPA-HQ-OAR-2006-0159-0019", "EPA", "EPA-HQ-OAR-2006-0159", "Letter to Brian McLean, Director, Office of Atmospheric Programs, USEPA re: responding to the March 23 letter requesting the Food and Drug Administration's (FDA) re: 2007 Essential Use Allowances", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:44Z", null, 0, 0, "09000064801dbe6a"], ["EPA-HQ-OAR-2006-0159-0003", "EPA", "EPA-HQ-OAR-2006-0159", "Letter to Mr. Andrew C. von Eschenbach, M.D., Acting Commissioner of Food and Drugs, Food and Drug Administration", "Supporting & Related Material", "Letter, Memorandum, Email", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:34Z", null, 0, 0, "09000064801d7e7f"], ["EPA-HQ-OAR-2006-0159-0005", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Inyx USA, Ltd.\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:36Z", null, 0, 0, "09000064801d7f7a"], ["EPA-HQ-OAR-2006-0159-0011", "EPA", "EPA-HQ-OAR-2006-0159", "Placeholder for Inyx USA Ltd.'s response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:39Z", null, 0, 0, "09000064801dbd07"], ["EPA-HQ-OAR-2006-0159-0002", "EPA", "EPA-HQ-OAR-2006-0159", "CBI Placeholder for Armstrong Pharmaceuticals, Inc.\u2019s response to Section 114 letter", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:34Z", null, 0, 0, "09000064801d76c1"], ["EPA-HQ-OAR-2006-0159-0014", "EPA", "EPA-HQ-OAR-2006-0159", "Honeywell's response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:41Z", null, 0, 0, "09000064801dbd47"], ["EPA-HQ-OAR-2006-0159-0012", "EPA", "EPA-HQ-OAR-2006-0159", "3M's response to 114 letter regarding CFC stocks owned", "Supporting & Related Material", "Other", "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:40Z", null, 0, 0, "09000064801dbd1e"], ["EPA-HQ-OAR-2006-0159-0009", "EPA", "EPA-HQ-OAR-2006-0159", "United States' Nomination of The Aerosol Metered Dose Inhaler (MDI) As An Essential Use", "Supporting & Related Material", null, "2006-11-03T05:00:00Z", 2006, 11, null, null, "2006-11-03T13:00:38Z", null, 0, 0, "09000064801dbc8d"]], "truncated": false, "filtered_table_rows_count": 40, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "EPA-HQ-OAR-2006-0159"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159", "results": [{"value": "EPA", "label": "EPA", "count": 40, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&agency_id=EPA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 38, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159", "results": [{"value": 2006, "label": 2006, "count": 25, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&posted_year=2006", "selected": false}, {"value": 2007, "label": 2007, "count": 15, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&posted_year=2007", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet=posted_month"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet=last_modified"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=EPA-HQ-OAR-2006-0159&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 266.1676029674709, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}